Table of contents
- Introduction
- Background of the dispute
- AstraZeneca’s ‘best reasonable efforts’ obligation
- Problems at AstraZeneca’s Belgian production plant
- AstraZeneca’s vaccines produced in the UK?
- Penalties or tools at the EU’s disposal
Article summary
Life Sciences analysis: The EU-AstraZeneca agreement imposes a ‘best reasonable efforts’ obligation on AstraZeneca to manufacture and deliver its coronavirus (COVID-19) vaccine doses to the EU. Christophe Ronse and Kirian Claeye of ALTIUS discuss this obligation and whether AstraZeneca is allowed under the agreement to prioritise supply of the UK over the EU with its vaccines produced in the UK.
To continue reading this news article, as well as thousands of others like it, sign in with LexisNexis or register for a free trial